Lecture 1- Cell Biology and Society Flashcards
Topic 1- mRNA vaccines and COVID
Who first suggested synthetic mRNAs? and for what?
- Katalin Kriko, Hungarian-born scientist at UPenn
- Suggested as a means to address diseases
But she didn’t get grant money and was demoted
Topic 1- mRNA vaccines and COVID
What were the two problems with mRNA?
- mRNA causes an immune reaction
- mRNA can be degraded
Topic 1- mRNA vaccines and COVID
What was the solution for mRNA causing an immune reaction and being degraded?
changing a few of the bases, called modified mRNA
Topic 1- mRNA vaccines and COVID
What needed to be overcome once modified mRNA was developed?
How to get the naked mRNA into cells so that it could synthesize the target protein of itnerest and secrete it
(inject lipid nanoparticles)
Topic 1- mRNA vaccines and COVID
How did modified mRNA become a big thing? (critical application)
- Bio tech companies like Pfizer/BionTech and Modera took notice, and COVID hit with a vengance
What was Katalin Kariko awarded a nobel prize for?
- Nobel Prize in Physiology or Medicine for her work with Drew Weissman in 2023
- for mRNA idea
Topic 1- mRNA vaccines and COVID
mRNA vs. trad vaccine: components
- mRNA vaccine: contains mRNA
- trad vaccine: contains microbial protein or inactive microbe
Topic 1- mRNA vaccines and COVID
mRNA vs trad vaccine: production
mRNA: faster bc mRNA molecules are easier to produce
trad vaccine: slower and more difficult to produce the right type of protein
Topic 1- mRNA vaccines and COVID
mRNA vs trad vaccine: process
mRNA: components injected into the arm and serve as instructions for the body to make microbial protein. Closely mimics a native viral infection leading to B and T cell responses
Topic 1- mRNA vaccines and COVID
mRNA and trad vaccine similarities
- both are antigens determined for immune stimulation
- both teach the body to protect itself against a microbe
Topic 2: Plants
“Fighting Cancer with a Pinch of Parsley and Dill” (seed)
- extracts from parsley ad dill seeds are a new source of a precursor of GVA (an antimitotic drug now more easily synthesized)
- GVA inhibits the growth of tumor cells by halting cells in mitosis and is not cytotoxic to normal cells
- CellInsight Cx5 High Contenct Screening (HCS) used to visualize
Topic 2: Plants
What is GVA?
an antimitotic drug that inhibits the growth of tumor cells by halting cells in mitosis, but is not cytotoxic to normal cells
Topic 2: Plants
What is CellInsight CX5 High Content Screening (HCS)?
- automated imaging platform that acquires high-resolution images of stained cells
- allows researchers to evaluate the effects of various drugs on cellular functions by capturing and analyzing images of cells in large quantities (valuable for large-scale, high-throughput experiments in drug discovery)
- Gains quantitative data
Topic 2: Plants
Making Photosynthesis better
- photosynthesis efficiency is less than solar panels (range around 0.1%-2% effective)… but works well enough that evolution doesn’t try to improve it
- So scientists try to improve it
Topic 2- Plants
1/4/2019: “Synthetic glycolate metabolism pathways stimulate crop growth and productivity in the field”
- Major enzyme (RUBISCO) in photosynthesis sometimes uses oxygen rather than CO2, resulting in glycolate (which is toxic). Wasteful process called photorespiration- reduces efficiency by 50%
- So, researchers from the USDA and U of Illinois made transgenic tobacco plants (model organisms) that process glycolate in only one cellular compartment rather than throughout the entire cell.
- As a result, photosynthesis improved and plants grew 40% more biomass
Topic 2: Plants
12/9/2022: “Photosynthetic Mammalian Cells Slow Degenerative Disease”
- Researchers have generated photosynthetic human cells by transplanting “nanothylakoid units (NTU)” (engineered mini chloroplasts) into them
- When transplanted into degenerating cells in mice with osteoarthritis and illuminated, disease progression is prevented
- Works because NTUs produce ATP and NADPH (more energy and reducing agents) that may also be important to prevent againg as well as diseases
Topic 2: Plants
1/14/2021: “Plant-based Biomanufacturing a Growing Trend”
- Most biologics (drugs that are either made in cells through genetic engineering or harvested from native plants…come from something living) are generated in animal cells
- But now many like Pfizer’s elelyso to treat Gaucher disease is made in plants
- Department of Defense (DARPA) currently has a $100 M grant programto support plant biopharmaceutical technology
Topic 3- Transplants
Overview from “Transplants Without a Waiting List- Can Cell Biologics Help?”
- UNOS- United Network for Organ Sharing
- Demand outpaces the supply
- But 3-D tissue engineering may alter the transplant landscape
Topic 3- Transplants
3/21/2024: HMS+MGH, “In a First, Genetically Edited Pig Kidney is Transplanted into Human”
- Physicians transplanted a genetically engineered pig kidney that had 69 genes modified to make it less likely to cause immune rejection when transplanted into a patient (Xenotransplantation). The patient died 2 months later
- This pioneering “compassionate case” speaks to the power of cell/molecular biology and its role in the future of organ transplants
Topic 3- Transplants
Do we know enough about cell and molecular biology to make an artificial organ or tissue?
- Yes- it has been done
- Tissue engineering is a sub-discipline of regenerative medicine… includes building tissues in the lab that can use adult stem cells, somatic cells, or human embryonic stem cells
Topic 3- Transplants
“Organoid Culture to Match Human Small Intestines”
- Tissue engineered intestinal organoids developed in the Netherlands that generate paneth cells
- Not previously inclued in intestinal organoids, Paneth cells defend the intestine from pathogens with secreted proteins called “defensins”
- Defective or missing Paneth cells occurs in diseases such as inflammatory bowel disease
- So, this model better represents a tissue construct that can be used for testing new drugs for intestinal diseases
Topic 3- Transplants
Fully Functioning Artificial Human Heart Muscle Organoids
- Several research teams are developing cardiac organoids
- They could be used in the future as “band aids” subsequent to a cardiac event such as an infarct
- Alternatively, they could be used for drug discovery to identify drugs that can treat arrhythmia
- Tracy Hookway’s lab (Natalie Pachter) in BU’s BME is developing a cardiac fibrosis model that could in the future help screen for drugs that can treat cardiac fibrosis
Topic 3- Transplants
But can we make multi-chambered heart organoids? “Multi-Chambered Heart Organoids Allow Study of Organ Development and Defects”
- Scientists in Austria have developed a multi-chamber organoid that mirrors the heart’s intricate structure
- Applications: not for transplant but can be used in drug development and toxicology studies as well as heart development and defects
- Importance: cardiovascular disease is the leading cause of death worldwide
Topic 3- Transplants
“Organoids” such as a brain organoid can be generated from a variety of stem cells. But, can we transplant animal neurons into human brains to regenerate damaged circuits (may be possible in future)? “In a First, Neurons from Rat Stem Cells Regnerate Brain Circuits in Mice”
- Rat olfactory (smell) neural circuits were restored by mice stem cells that formed circuits in rats that lacked the circuit
- This suggests that this restorative application may be possible in aging or diseased humans using cells generated from humans or animals